Logo-jnp
J Nephropathol. 2017;6(1): 15-24. doi: 10.15171/jnp.2017.04
PMID: 28042549        PMCID: PMC5106878

Original Article

Relationship between IL-17 and ambulatory blood pressure inpolycystic ovary syndrome

Fatemeh Foroozanfard 1, Alireza Soleimani 2, Elham Arbab 1, Mansooreh Samimi 1, Mohammad Reza Tamadon 3 *

Cited by CrossRef: 15

1- Özay A, Özay Ö. The importance of inflammation markers in polycystic ovary syndrome. Rev Assoc Med Bras. 2021;67(3):411 [Crossref]
2- Liu A, Liao H, Zhou J, Nie Y, Zhou C, Li Z, Guo Z, He D, Zhu Y, Peng C. The role of FTO variants in the susceptibility of polycystic ovary syndrome and in vitro fertilization outcomes in Chinese women. Gynecological Endocrinology. 2018;34(8):719 [Crossref]
3- Ebrahimi Chaharom F, Ebrahimi A, Feghhi Koochebagh F, Babalou Z, Ghojazadeh M, Aghebati Maleki L, Nader N. Association of IL-17 serum levels with clinical findings and systemic lupus erythematosus disease activity index. Immunological Medicine. 2023;46(4):175 [Crossref]
4- Baloushah S, Barjasteh S, Elsous A, Aldirawi A, Abu Eid S, Masad A. Quality of life of infertile couples in the Gaza Strip, Palestine. 2021;10(6):262 [Crossref]
5- Falahatian S, Haddad R, Pakravan N. Modulatory effects of R10 fraction of garlic (Allium sativum L.) on hormonal levels, T cell polarization, and fertility-related genes in mice model of polycystic ovarian syndrome. J Ovarian Res. 2022;15(1) [Crossref]
6- Luan Y, Zhang L, Peng Y, Li Y, Liu R, Yin C. Immune regulation in polycystic ovary syndrome. Clinica Chimica Acta. 2022;531:265 [Crossref]
7- Xu W, Tang M, Wang J, Wang L, Kennedy D. Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine. 2020;2020(1) [Crossref]
8- Hadi Khorsheed Z, Al-shibly I, Gatea A. Relationship Between Human Cytomegalovirus and IL-17A in Iraqi Women with Polycystic Ovary Syndrome. Al-Rafidain J Med Sci. 2024;6(2):178 [Crossref]
9- Ullah A, Wang M, Yang J, Adu-Gyamfi E, Czika A, Sah S, Feng Q, Wang Y. Ovarian inflammatory mRNA profiles of a dehydroepiandrosterone plus high-fat diet-induced polycystic ovary syndrome mouse model. Reproductive BioMedicine Online. 2022;44(5):791 [Crossref]
10- Zanjirband M, Baharlooie M, Safaeinejad Z, Nasr-Esfahani M. Transcriptomic screening to identify hub genes and drug signatures for PCOS based on RNA-Seq data in granulosa cells. Computers in Biology and Medicine. 2023;154:106601 [Crossref]
11- Sarhat E, Abid I, Kamel N, Sarhat T, Abass K. Changes of serum Interleukin and Chemerin levels in patients with Polycystic Ovary syndrome. J Adv Pharm Educ Res. 2021;11(4):11 [Crossref]
12- Moulana M. Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes. Life. 2023;13(4):1010 [Crossref]
13- Dey R, Bhattacharya K, Basak A, Paul N, Bandyopadhyay R, Chaudhuri G, Purkait M, Bhattacharjee A, Bose C, Shukla N, Bhaduri R, Roy S, Syamal A. Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers. Middle East Fertil Soc J. 2023;28(1) [Crossref]
14- Zheng M, Zhao F. The IL-12 family of heterodimeric cytokines in polycystic ovarian syndrome: biological role in induction, regulation, and treatment. Immunol Res. 2024;72(4):583 [Crossref]
15- Zhang Y, Cao S, Liang J, Ge X, Hu S, Li Y, Li L. The efficacy of Fuke Qianjin tablets combined with clomiphene citrate on infertility patients with polycystic ovary syndrome: A retrospective analysis. 2023;102(27):e34162 [Crossref]